Annovis Bio ANVS
NYSE ANVS
$0.83 -0.07 (-7.42%)
As of: Nov 10, 2026 · 2:53 PM EST

Annovis Bio (ANVS) Revenue (2019 - 2024)

Updated

Analysis

Annovis Bio (ANVS) Revenue (2019 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 25.40 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 17.40 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 15.38 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 8.30 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 16.58 Bn
10 Annovis Bio 32.15 Mn -35.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 25,978.00
Mar 31, 2024 44,168.00
Dec 31, 2023 66,130.00
Sep 30, 2023 146,655.00
Jun 30, 2023 222,578.00
Mar 31, 2023 232,535.00
Dec 31, 2022 74,153.00
Sep 30, 2022 52,886.00
Jun 30, 2022 36,024.00
Mar 31, 2022 19,649.00
Dec 31, 2021 5,450.00
Sep 30, 2021 5,554.00
Jun 30, 2021 2,134.00
Mar 31, 2021 197.00
Dec 31, 2020 213.00
Sep 30, 2020 10,500.00
Jun 30, 2020 25,878.00
Mar 31, 2020 10,634.00
Dec 31, 2019 -12,369.00
Sep 30, 2019 -12,327.00
API Access

Annovis Bio Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ANVS&period=max&api_key=YOUR_API_KEY